Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|February 25, 2025
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumorsSusan C Scott, Anna Farago, W Victoria Lai, et al.
Molecular Cancer Therapeutics|December 4, 2025
Inhibition of CDKs Enhances Efficacy of Anti-EGFR Therapy in ChordomaTianna Zhao, Riccardo Serra, Michelle Guo, et al.
Clinical Lung Cancer|December 31, 2023
Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non-Small-Cell Lung CancerPaola Ghanem, Joseph C Murray, Melinda Hsu, et al.
JTO Clinical and Research Reports|July 8, 2024
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound MutationsTia Cheunkarndee, Matthew Z Guo, Stefanie Houseknecht, et al.
The Oncologist|October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief reportPatrick M Forde, Craig M Hooker, Sosipatros A Boikos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung CancerLavanya Sivapalan, Wade T Iams, Zineb Belcaid, et al.
Clinical Lung Cancer|August 31, 2022
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung CancerMatthew Z Guo, Joseph C Murray, Paola Ghanem, et al.
Cancer|May 11, 2016
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)Chandra P Belani, Suzanne E Dahlberg, Charles M Rudin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 TrialCharles M Rudin, Melissa L Johnson, Luis Paz-Ares, et al.
Pageof 14